PLoS ONE (Jan 2017)

Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.

  • Rosario Vasta,
  • Alessandra Nicoletti,
  • Giovanni Mostile,
  • Valeria Dibilio,
  • Giorgia Sciacca,
  • Donatella Contrafatto,
  • Calogero Edoardo Cicero,
  • Loredana Raciti,
  • Antonina Luca,
  • Mario Zappia

DOI
https://doi.org/10.1371/journal.pone.0172145
Journal volume & issue
Vol. 12, no. 2
p. e0172145

Abstract

Read online

INTRODUCTION:Acute levodopa challenge may be performed to predict levodopa chronic responsiveness. The aim of the study was to investigate frequency of side effects during the acute levodopa challenge in PD and atypical parkinsonisms. METHODS:We enrolled 34 de novo PD patients and 29 patients affected by atypical parkinsonisms (Multiple System Atrophy, MSA, n = 10; Progressive Supranuclear Palsy, PSP, n = 12 and Corticobasal Degeneration, CBD, n = 7) who underwent an acute levodopa challenge. Side effects occurring during test were recorded. RESULTS:Side effects were more frequent among atypical parkinsonisms as unique group when compared to PD patients (64.3% versus 23.5%; p-value 0.002) with an adjusted OR of 4.36 (95%CI 1.40-13.5). Each atypical parkinsonisms showed almost double occurrence of side effects (MSA 90%, PSP 41.7% and CBD 57%). CONCLUSIONS:Side effects during acute levodopa challenge may be frequent in atypical parkinsonisms. This information could be useful in order to better prepare the patient for the test. Furthermore, it could represent a useful cue in differential diagnosis with PD.